• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Artificial placenta holds promise for extremely premature infants

, 26 August 2020/in E-News /by 3wmedia

The development of an artificial placenta – used successfully in premature lambs – could revolutionize the treatment of extreme prematurity.
Researchers at the University of Michigan are working to improve survival rates in the tiniest, most premature babies in a ground-breaking way: through an artificial placenta that mimics the womb.
The technology hasn’t reached a clinical trial, but researchers from U-M’s C.S. Mott Children’s Hospital and Extracorporeal Circulation Research Laboratory are making dramatic progress. An extracorporeal artificial placenta at the institution has kept five extremely premature lambs alive for a week. The lambs were transferred to the artificial placenta, which utilizes extracorporeal membrane oxygenation (ECMO), without ever taking their first breath.
The ultimate goal of nearly a decade of sustained work would be for an artificial placenta to help extremely premature babies with the greatest risks of disability or death continue critical organ development outside of their mother’s womb.
Despite significant advances in the treatment of prematurity, the risk of death and long-term disability remains high for extremely premature infants (born before 24 weeks). Their bodies simply are not prepared for life outside the womb.
‘One of the gravest risks for extremely premature babies is undeveloped lungs that are too fragile to handle even the gentlest ventilation techniques,’ says George Mychaliska, M.D., the principal investigator and the director of U-M’s Fetal Diagnosis and Treatment Center. ‘If a baby’s lungs are severely immature, they cannot provide the brain, heart and other organs the oxygen they need to survive.’
Mychaliska, who has been referred to as Michigan’s ‘fetus fixer’ for his renowned fetal intervention work, has been leading research to improve outcomes for premature infants.
‘We thought, Why don’t we solve the problem of prematurity by re-creating the intrauterine environment?” he says. ‘Maybe we should treat this tiny baby like a fetus. Maybe we should treat these babies as if they are still in the womb. This is a complete paradigm shift. Our research is still in a very preliminary stage, but we’ve passed a significant milestone that gives us promise of revolutionizing the treatment of prematurity.
‘Although many of our current therapies are lifesaving, they are not designed for premature babies and are often ineffective or contribute to complications,’ he adds.
The innovative artificial placenta simulates the intrauterine environment and provides gas exchange without mechanical ventilation. By recapitulating normal fetal physiology to re-create the intrauterine environment, the artificial placenta holds the promise of normal growth and development outside the womb for extremely premature infants until they are ready for postnatal life.
The success of keeping lambs alive through this technique was a crucial milestone in securing a $2.7 million ( Euro 2.4 million) R01 National Institutes of Health grant to accelerate this research.
Over the next five years, researchers expect to demonstrate that an artificial placenta can simulate the intrauterine environment and support a foetal lamb from extreme prematurity to normal newborn physiology. The next step would be to determine if the milestones would justify preliminary clinical trials in extremely premature babies.

University of Michigan http://tinyurl.com/zzhz9o3

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:07Artificial placenta holds promise for extremely premature infants

Safer, faster heart scans in view

, 26 August 2020/in E-News /by 3wmedia

A team of Oxford University researchers has developed a technique that could improve heart scans for patients, giving more information about the heart than traditional scans and without any injections, making them safer and faster.
The group of medical, physics and engineering researchers are based at the Oxford Centre for Clinical Magnetic Resonance Research (OCMR). They are using a property of hydrogen atoms to create a pixel-by-pixel map of the heart, called a T1-map, which allows examination of healthy and diseased heart tissue in greater detail than before.
Currently, stress scans of the heart using magnetic resonance imaging (MRI) require patients to be injected with two substances. Adenosine is a medication injected into the patient that causes effects similar to exercise during the scan. Gadolinium – a rare earth heavy metal – is injected as a contrast agent to highlight areas of the heart suffering from decreased blood flow under exercise conditions.
Patients with severe kidney failure – who are usually at higher risk for heart disease – cannot clear Gadolinium and often are unable to benefit from a full MRI scan of the heart. T1-maps can potentially solve this problem in the future.
Dr Alexander Liu, who leads the research with the guidance of his supervisors – Dr. Vanessa Ferreira, Dr. Stefan Piechnik and Professor Neubauer (the centre director), explained: We wanted to see if using T1 mapping can give clearer, more clinically-useful results compared to traditional MRI scans that require injections of contrast agents. On traditional MRI scans, doctors are judging relative shades of light and dark on a scan, and even the most experienced specialists can disagree on what the image is showing them. T1 maps provide an objective number, which can be coded in colours, and may be less subjective. Additionally, patients with severe kidney failure – who are usually at higher risk for heart disease – cannot clear Gadolinium and often are unable to benefit from a full MRI scan of the heart. T1-maps can potentially solve this problem in the future.’
In physics, T1 is the time constant that describes how quickly atoms return to normal thermodynamic state after being affected by radio waves and strong magnetic fields. Just like measuring body temperature in Celsius or Fahrenheit, the numbers themselves may not mean much, but any deviation from established normal ranges can suggest disease. In the case of T1 mapping, long T1 times indicate the presence of more water, something found in a number of heart conditions, including areas of the heart suffering from lack of blood supply due to blocked arteries. A T1-map just helps to visualize T1 values across the heart and find the precise location of the problem. It takes around three minutes to map the whole heart, and the values it measures are turned into a colour map, giving doctors an image which is potentially quicker to understand with less subjective interpretation.
Dr Stefan Piechnik developed the specific T1 mapping technique at Oxford, named ShMOLLI. He said: T1 mapping allows us to look in finer detail at the heart in a non-invasive way, which has not been possible before. We can now get results without Gadolinium, meaning we have a technique that is safer and quicker and can be used with more people. The results are also less dependent on interpreting the images – medics have something based on hard numbers.’

Oxford University http://tinyurl.com/h4ruhca

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:15Safer, faster heart scans in view

Artificial Intelligence may aid in Alzheimer’s diagnosis

, 26 August 2020/in E-News /by 3wmedia

Machine learning is a type of artificial intelligence that allows computer programs to learn when exposed to new data without being programmed. Now, researchers in The Netherlands have coupled machine learning methods with a special MRI technique that measures the perfusion, or tissue absorption rate, of blood throughout the brain to detect early forms of dementia, such as mild cognitive impairment (MCI), Radiology.
‘MRI can help with the diagnosis of Alzheimer’s disease,’ said principal investigator Alle Meije Wink, Ph.D., from the VU University Medical Centre in Amsterdam. ‘However, the early diagnosis of Alzheimer’s disease is problematic.’

Scientists have long known that Alzheimer’s disease is a gradual process and that the brain undergoes functional changes before the structural changes associated with the disease show up on imaging results. Physicians have no definitive way of identifying who has early dementia or which cases of mild cognitive impairment will progress to Alzheimer’s disease.

‘With standard diagnostic MRI, we can see advanced Alzheimer’s disease, such as atrophy of the hippocampus,’ Dr. Meije Wink said. ‘But at that point, the brain tissue is gone and there’s no way to restore it. It would be helpful to detect and diagnose the disease before it’s too late.’

For the new study, the researchers applied machine learning methods to special type of MRI called arterial spin labelling (ASL) imaging. ASL MRI is used to create images called perfusion maps, which show how much blood is delivered to various regions of the brain.

The automated machine learning program is taught to recognize patterns in these maps to distinguish among patients with varying levels of cognitive impairment and predict the stage of Alzheimer’s disease in new (unseen) cases.
The study included 260 of 311 participants from the Alzheimer Center of the VU University Medical Center dementia cohort who underwent ASL MRI between October 2010 and November 2012.

The study group included 100 patients diagnosed with probable Alzheimer’s disease, 60 patients with mild cognitive impairment (MCI) and 100 patients with subjective cognitive decline (SCD), and 26 healthy controls.
SCD and MCI are considered to be early stages of the dementia process and are diagnosed based on the severity of cognitive symptoms, including memory loss and thought- and decision-making problems.

The automated system was able to distinguish effectively among participants with Alzheimer’s disease, MCI and SCD. Using classifiers based on the automated machine learning training, the researchers were then able to predict the Alzheimer’s diagnosis or progression of single patients with a high degree of accuracy, ranging from 82 percent to 90 percent.
‘ASL is a promising alternative functional biomarker for the early diagnosis of Alzheimer’s disease,’ Dr. Meije Wink said.

Radiological Society of North Americawww2.rsna.org/timssnet/media/pressreleases/14_pr_target.cfm?ID=1890

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:23Artificial Intelligence may aid in Alzheimer’s diagnosis

Reed Sinopharm hosts world’s largest healthcare event – tHIS in Shanghai

, 26 August 2020/in E-News /by 3wmedia

The Health Industry Summit (tHIS) 2016 was held in Shanghai at the National Exhibition and Convention Centre from 17 to 20 April.

The organizer posted a record 380,000 entry scans, 216,784 professional visitors and more than 55,000 exhibiting staff to the venue over four days. In preparation of the large concentration of visitors, the city of Shanghai initiated its municipal level security mechanism and increased the frequency of the subway to divert the large crowds and dense traffic to the venue. Hotels were also fully booked in Shanghai during the event period.
Only in its second edition, tHIS has already been firmly established as the world’s largest health industry event with over 330,000 square meters of exhibition space and 107 individual conferences.
Key events included China’s three top medical equipment and pharmaceutical exhibitions (CMEF, PHARMCHINA and API China) and the leading healthcare investment forum – Healthcare China 2016. This year’s investment forum was co-organized by Reed Sinopharm, JP Morgan Asset management, CICC and Sinopharm Capital and was attended by more than 700 selected investors and institutions.
The exhibition featured the entire industry value chain and presented some of the latest cutting edge technology including genetic diagnostics, rehabilitation robotics, wearable tech, 3D printing and more.
6,900 exhibiting companies from 30 countries were at the show presenting tens of thousands of products and services. Well-known healthcare equipment giants like GE, United Imaging, Siemens, Philips and Mindray as well as major pharmaceutical groups in China like Sinopharm, Shanghai Pharma and CR Pharmaceuticals were in attendance with major stand presence.
Natural Health and Nutrition Expo were among the fastest growing segments in the portfolio, helped by the expected population boom in light of the reversal of the single child policy as well as a growing health-conscious middle class in China.
With the start of China’s 13th Five-year plan in 2016, the ‘Health China 2020’ programme focusing on the co-development of healthcare, pharmaceutical production and health insurance has put the health industry among the top priorities for development in China and part of the national strategy.
Companies in China not traditionally associated with healthcare have also shifted major investment and resources into the sector, many renaming their company in the process to reflect this focus in industry coverage. International giants with the likes of Alibaba, Lenovo, Fosun and Wanda Group have all taken a foothold into key segments of the industry in anticipation of major opportunities in the future.
The Health Industry Summit is organized by Reed Sinopharm, a joint venture between the world’s leading event organizer Reed Exhibitions and China’s leading state-owned pharmaceutical group Sinopharm. Its next edition will be held in May 2017 in Shanghai.

www.thishealthsummit.com/en/index.jhtml

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:10Reed Sinopharm hosts world’s largest healthcare event – tHIS in Shanghai

Exercise can tackle symptoms of schizophrenia

, 26 August 2020/in E-News /by 3wmedia

Aerobic exercise can significantly help people coping with the long-term mental health condition schizophrenia, according to a new study from University of Manchester researchers.

Through combining data from 10 independent clinical trials with a total of 385 patients with schizophrenia, Joseph Firth found that around 12 weeks of aerobic exercise training can significant improve patients’ brain functioning.

The study was by Firth, Dr Brendon Stubbs and Professor Alison Yung.

Schizophrenia’s acute phase is typified by hallucinations and delusions, which are usually treatable with medication.

However, most patients are still troubled with pervasive cognitive deficits’; including poor memory, impaired information processing and loss of concentration.

The research showed that patients who are treated with aerobic exercise programs, such as treadmills and exercise bikes, in combination with their medication, will improve their overall brain functioning more than those treated with medications alone.
The areas which were most improved by exercising were patients’ ability to understand social situations, their attention spans, and their working memory’ – or how much information they can hold in mind at one time.

There was also evidence among the studies that programs which used greater amounts of exercise, and those which were most successful for improving fitness, had the greatest effects on cognitive functioning.

Joe Firth said: ‘Cognitive deficits are one aspect of schizophrenia which is particularly problematic.

‘They hinder recovery and impact negatively upon people’s ability to function in work and social situations. Furthermore, current medications for schizophrenia do not treat the cognitive deficits of the disorder.

‘We are searching for new ways to treat these aspects of the illness, and now research is increasingly suggesting that physical exercise can provide a solution.’

He added: ‘These findings present the first large-scale evidence supporting the use of physical exercise to treat the neurocognitive deficits associated with schizophrenia.

‘Using exercise from the earliest stages of the illness could reduce the likelihood of long-term disability, and facilitate full, functional recovery for patients.’

University of Manchester www.manchester.ac.uk/discover/news/exercise-can-tackle-symptoms-of-schizophrenia/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:18Exercise can tackle symptoms of schizophrenia

Non-narcotic nerve block controls children’s pain

, 26 August 2020/in E-News /by 3wmedia

A congenital condition called pectus excavatum, in which a child’s breastbone is sunken into the chest, can be corrected through minimally invasive surgery, but pain control after the operation can be a challenge. A Mayo Clinic study has found an effective way to control pain and reduce opioid painkiller use after surgery: sending children home with catheters that infuse a non-narcotic nerve-blocking drug called a paravertebral blockade. Use of the blocks shortens hospital stays and reduces opioid use after surgery, the researchers discovered.
The study focused on pain control after children receive a Nuss procedure, in which small incisions are made and a stainless steel or titanium bar is placed under the sternum to reshape the chest wall. Researchers looked at the cases of 132 children who had Nuss surgery from 2010 through 2015. Of those, 114 received paravertebral catheters and continued receiving the infusions for two to five days after returning home. Eighteen were instead given an epidural.
Use of paravertebral catheters cut the median hospital stay by roughly a day and a half from 120 hours to 80 hours, the researchers found. Opioid painkiller consumption also decreased. Opioids can have significant side effects that slow recovery after surgery, including drowsiness, light-headedness, nausea, constipation and risk of falls.
‘Our operation is minimally invasive, but it produces major changes in the chest wall. Pain was an issue for our patients, but this new technique has solved the problem. It’s better than an epidural, because it’s reliable, and kids can go home with it. For the first time, we consistently deliver on our promise to minimize pain,’ says co-author Christopher Moir, M.D., a pediatric and thoracic surgeon in the Mayo Clinic Children’s Center.
Chest wall deformities are fairly common. Pectus excavatum, also called funnel chest, is the most frequent. The sunken breastbone is noticeable when a child is born and typically worsens during the adolescent growth spurt. Even mild cases can cause children to feel self-conscious. Severe cases can interfere with heart and lung function.
Epidurals have been a standard method to manage pain after pectus excavatum surgery, but they are stopped before children leave the hospital, and severe pain may persist after that. Many hospitals, including Mayo Clinic, have been using other options, such as nerve blocks, patient-controlled painkiller delivery and non-narcotic painkiller injections. There has been little consistent data on pain outcomes.
‘This study puts solid data to what we see each day in the hospital and what families tell us. Paravertebal catheters work,’ Dr. Moir says.

Mayo Clinichttp://tinyurl.com/zqbbaz5

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:38:032020-08-26 14:38:26Non-narcotic nerve block controls children’s pain

Early echocardiography to study pulmonary hypertension in mouse model of bronchopulmonary dysplasia

, 26 August 2020/in E-News /by 3wmedia

Sooner is always better when it comes to diagnosing an illness and this is especially true when it comes to lung disease in premature infants, since it can have an impact on a child’s health in the long-term. Researchers at Baylor College of Medicine who focus on bronchopulmonary dysplasia and pulmonary hypertension, a common lung disease in premature infants, have shown that echocardiography can be used to detect the pulmonary hypertension in neonatal mice at an earlier time point than previously thought.
Bronchopulmonary dysplasia is caused by many factors, including inflammation, infection and oxidative stress. Dr. Binoy Shivanna, assistant professor of pediatrics – neonatology at Baylor and Texas Children’s Hospital, and colleagues focus on the oxidative stress and inflammation aspects of the disease, which can damage various parts of the cell and interrupt the development of the lungs. This can lead to problems such as pulmonary hypertension which increases the mortality and long-term problems in infants.
Progress developing improved treatments for the disease has been limited in part by the lack of advanced imaging techniques to detect pulmonary hypertension and lung damage at earlier time points in animal models, which is important to test these potential new treatments. This model could also help researchers better understand how pulmonary hypertension develops, which is an important aspect of Shivanna’s research. So the team set out to develop a mouse model of the disease that replicates many of the features observed in infants with the condition.
To induce oxidative stress and inflammation – two contributing factors of the development of the disease – the researchers exposed a group of newborn mice to 70 percent of oxygen or hyperoxia for 14 days, while a control group received 21 percent oxygen or regular air.
The mice exposed to hyperoxia developed lung oxidative stress, inflammation and lungs that resembled those typical of bronchopulmonary dysplasia and pulmonary hypertension in infants. Furthermore, echocardiography tests performed in the young mice showed that the animals had also developed pulmonary hypertension.
‘It’s important to understand not only the pathology, but also the functional aspect of pulmonary hypertension,’ said Shivanna. ‘This is where the echocardiography test, a non-invasive test that uses high frequency sound waves to take pictures of the heart, comes in.’
Currently, echocardiography tests have been performed in mice at four weeks of age, which might be too late to intervene. Using the latest advances in research technology, Shivanna and colleagues were able to demonstrate that it is possible to functionally detect pulmonary hypertension at an earlier time point, meaning that interventions could potentially take place sooner.
This mouse model can help researchers develop early interventions to prevent or decrease the severity of some of the later onset diseases, such as chronic obstructive pulmonary disease.

Baylor College of Medicine http://tinyurl.com/h3su3ph

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:38Early echocardiography to study pulmonary hypertension in mouse model of bronchopulmonary dysplasia

Use of benzodiazepines and related drugs common around Alzheimer’s diagnosis

, 26 August 2020/in E-News /by 3wmedia

Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer’s disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland. Benzodiazepines and related drugs are used as a sleep medication and for anxiolytic purposes. These drugs were initiated more frequently in persons with Alzheimer’s disease than in persons not diagnosed with AD. Compared to persons not diagnosed with AD, it was three times more likely for persons with Alzheimer’s disease to initiate benzodiazepine use after the diagnosis, and benzodiazepines were most commonly initiated six months after the diagnosis.

The findings are based on data from the Finnish Medication Use and Alzheimer’s Disease Study, Medalz. Medalz comprises nationwide, extensive register-based data from the Finnish health care registers, and it includes all persons diagnosed with Alzheimer’s disease in Finland between 2005 and 2011. The study, analysed the initiation of benzodiazepines and related drugs in 51,981 persons diagnosed with AD. Their use of drugs was monitored for a period of five years, and the follow-up started already two years before the diagnosis. The findings were compared to persons not diagnosed with Alzheimer’s disease who were matched based on age and gender.

According to the Finnish Current Care Guidelines, benzodiazepines can be used on a short-term basis to treat behavioural problems associated with Alzheimer’s disease. However, data on the benefits of these drugs in the treatment of behavioural problems is insufficient, but it is known that these drugs increase the risk of falls and cause cognitive impairment.

One of the earlier studies on Medalz study found that in Finland, benzodiazepines are used for extensive periods in persons with Alzheimer’s disease. This, together with the current finding of frequent initiations of these drugs, paints a picture of a possible delay in AD diagnoses and concerning practice of symptom-based treatment before and around diagnosis.

University of Eastern Finland www.uef.fi/en/-/bentsodiatsepiinien-ja-niiden-kaltaisten-laakkeiden-kaytto-yleistyy-alzheimerin-taudin-toteamisen-aikoihin

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:47Use of benzodiazepines and related drugs common around Alzheimer’s diagnosis

Watching the brain in action

, 26 August 2020/in E-News /by 3wmedia

Watching millions of neurons in the brain interacting with each other is the ultimate dream of neuroscientists! A new imaging method now makes it possible to observe the activation of large neural circuits, currently up to the size of a small-animal brain, in real time and three dimensions. Researchers at the Helmholtz Zentrum Munchen and the Technical University of Munich have recently reported on their new findings.
Nowadays it is well recognized that most brain functions may not be comprehended through inspection of single neurons. To advance meaningfully, neuroscientists need the ability to monitor the activity of millions of neurons, both individually and collectively. However, such observations were so far not possible due to the limited penetration depth of optical microscopy techniques into a living brain.
A team headed by Prof. Dr. Daniel Razansky, a group leader at the Institute of Biological and Molecular Imaging (IBMI), Helmholtz Zentrum Munchen, and Professor of Molecular Imaging Engineering at the Technical University of Munich, has now found a way to address this challenge. The new method is based on the so-called optoacoustics, which allows non-invasive interrogation of living tissues at centimetre scale depths.
‘We discovered that optoacoustics can be made sensitive to the differences in calcium ion concentrations resulting from neural activity and devised a rapid functional optoacoustic neuro-tomography (FONT) system that can simultaneously record signals from a very large number of neurons’, said Dr. Xose Luis Dean-Ben, first author of the study. Experiments performed by the scientists in brains of adult zebrafish (Danio rerio) expressing genetically encoded calcium indicator GCaMP5G demonstrated, for the first time, the fundamental ability to directly track neural dynamics using optoacoustics while overcoming the longstanding penetration barrier of optical imaging in opaque brains. The technique was also able to trace neural activity during unrestrained motion of the animals.
‘So far we demonstrated real-time analysis on whole brains of adult animals with roughly 2x3x4 millimetre dimensions (approximately 24 mm3),’ says the study’s leader Razansky. State-of-the-art optical microscopy methods are currently limited to volumes well below a cubic millimetre when it comes to imaging of fast neural activity, according to the researchers. In addition, their FONT method is already capable of visualizing volumes of more than 1000 cubic millimetres with temporal resolution of 10 milliseconds.
Large-scale observation of neural activity is the key to understanding how the brain works, both under normal and diseased conditions. ‘Thanks to our method, one can now capture fast activity of millions of neurons simultaneously. Parallel neural networks with the social media: in the past, we were able to read along when someone (in this case, a nerve cell) placed a message with a neighbour. Now we can also see how this message spreads like wildfire,’ explains Razansky. ‘This new imaging tool is expected not only to significantly promote our knowledge on brain function and its pathophysiology but also accelerate development of novel therapies targeting neurological and neuropsychiatric disorders,’ he concludes.

Technical University of Munich http://tinyurl.com/goxtrm5

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:55Watching the brain in action

Silver ions prove effective in preventing, killing MRSA while forming bone

, 26 August 2020/in E-News /by 3wmedia

University of Missouri College of Engineering Dean and Bioengineering Professor Elizabeth Loboa and a team of colleagues recently discovered a way to slow and, in some cases, prevent the spread of MRSA while also regenerating new bone.

Methicillin resistant Staphylococcus aureus, or MRSA, infections are a critical problem in the medical world, including the area of regenerative medicine. This form of antibiotic-resistant staph infection can cause serious complications after typical invasive procedures and can be easily spread through skin-to-skin contact. MRSA is one of the foremost causes of osteomyelitis, a disease that inflames and destroys bone as well as surrounding soft tissue.

But University of Missouri College of Engineering Dean and Bioengineering Professor Elizabeth Loboa and a team of colleagues – Mahsa Mohiti-Asli and Casey Molina of the Joint Department of Biomedical Engineering at the University of North Carolina and North Carolina State University, Diteepeng Thamonwan of Silpakorn University in Thailand and Behnam Pourdeyhimi of NCSU – recently discovered a way to slow and, in some cases, prevent the spread of MRSA while also regenerating new bone.

Loboa and her colleagues discovered that by seeding the proper amount of silver into a biodegradable scaffold alongside bone-forming stem cells, they could still rapidly form bone while either inhibiting MRSA growth or killing the infection outright.

‘The silver ions go in and completely disrupt the MRSA cell machinery, and they can inhibit growth and kill the bacteria,’ Loboa said. ‘It’s a fine line. If you overuse too much of the silver, it’s bad for the mammalian cells. We want to make sure we don’t hurt our host cells but kill the bacterial cells.’

The threads of the bone-creating scaffold were coated with a silver ion-containing solution before testing. Silver has proven effective in undoing bacteria mechanically, making it harder for bacteria to develop immunity.

University of Missouri College of Engineering engineering.missouri.edu/2017/01/silver-ions-prove-effective-treating-killing-antibiotic-resistant-staph-infection/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:37:362020-08-26 14:37:41Silver ions prove effective in preventing, killing MRSA while forming bone
Page 178 of 237«‹176177178179180›»

Latest issue of International Hospital

April 2024

4 November 2025

Ageing populations are driving drug-resistant infection surge across Europe

31 October 2025

Experts challenge universal fluid protocols in septic shock treatment

31 October 2025

Breakthrough magnetic capsule robot integrates diagnosis and treatment for gastrointestinal diseases

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Tramstraat 15
5611CM Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription